首页 | 本学科首页   官方微博 | 高级检索  
     

三级淋巴结构在肿瘤免疫治疗中的研究进展
引用本文:董丽媛, 王燕妮, 鲁智豪. 三级淋巴结构在肿瘤免疫治疗中的研究进展[J]. 中国肿瘤临床, 2023, 50(14): 733-739. DOI: 10.12354/j.issn.1000-8179.2023.20230338
作者姓名:董丽媛  王燕妮  鲁智豪
作者单位:北京大学肿瘤医院暨北京市肿瘤防治研究所消化肿瘤内科,恶性肿瘤发病机制及转化研究教育部重点实验室(北京市100142)
基金项目:本文课题受国家自然科学基金项目重大研究计划培育项目(编号:92159106)资助
摘    要:三级淋巴结构(tertiary lymphoid structures,TLS)是指在病理生理环境下,淋巴细胞在非淋巴器官内聚集形成的有组织的异位淋巴结构。成熟的TLS包括被T细胞包围的B细胞区域和生发中心,普遍存在于多个瘤种中,是肿瘤细胞与免疫细胞相互作用的重要场所,与患者预后密切相关。因此,诱导形成TLS,使T细胞和B细胞发育分化为能够识别杀伤肿瘤细胞的效应细胞和记忆细胞,可以介导抗肿瘤免疫反应。本综述主要介绍了TLS的组成成分和形成过程,总结归纳现有的检测手段,强调了TLS不同成熟度、位置和内部组成等特征对肿瘤免疫疗效的影响和预测价值,并探讨诱导TLS作为肿瘤治疗手段的应用潜能。

关 键 词:三级淋巴结构  肿瘤微环境  预测标志物  B细胞  T细胞
收稿时间:2023-04-15
修稿时间:2023-06-19

Control of CD8 T-cell infiltration into tumors by vasculature and microenvironment
Liyuan Dong, Yanni Wang, Zhihao Lu. Research progress of tertiary lymphoid structures in tumor immunotherapy[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 50(14): 733-739. DOI: 10.12354/j.issn.1000-8179.2023.20230338
Authors:Liyuan Dong  Yanni Wang  Zhihao Lu
Affiliation:Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
Abstract:Tertiary lymphoid structures (TLS) are organized ectopic lymphoid tissues formed by lymphocyte aggregation in pathological environments. Mature TLS, including B-cell regions surrounded by T cells and germinal centers, have been identified in a wide variety of tumors. TLS offer sites of interaction between cancer cells and immune system cells in the tumor microenvironment (TME), and are closely associated with patient prognosis. It is thus necessary to induce TLS formation to allow T and B cells to develop and differentiate into effector and memory cells that recognize and kill cancer cells, and mediate anti-tumor immune responses. This review focuses on TLS formation and composition, and summarizes and compares existing techniques. We also emphasize the potential predictive roles of TLS development, location, and internal components as biomarkers of response to immunotherapy, and potential therapeutic strategies that induce TLS formation.
Keywords:tertiary lymphoid structures (TLS)  tumor microenvironment (TME)  predictive markers  B cells  T cells
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号